SEARCH

SEARCH BY CITATION

References

  • 1
    Ahmed, M.M., Mutimer, D.J., Elias, E., Linin, J., Garrido, M., Hubscher, S., Jarvis, L., Simmonds, P., Wilde, J.T. (1996) A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. British Journal of Haematology, 95, 383 388.
  • 2
    Darby, S.C., Ewart, D.W., Giangrande, P.L., Spooner, R.J., Rizza, C.R., Dusheiko, G.M., Lee, C.A., Ludlam, C.A., Preston, F.E. (1997) Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet, 350, 1425 1431.DOI: 10.1016/s0140-6736(97)05413-5
  • 3
    Di Bisceglie, A.M., Conjeevaram, H.S., Fried, M.W., Sallie, R., Park, Y., Yurdaydin, C., Swain, M., Kleiner, D.E., Mahaney, K., Hoofnagle, J.H. (1995) Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 123, 897 903.
  • 4
    Eisenburg, J. (1994) Interferon or C virus-induced autoimmune chronic hepatitis? Report of personal observations and review of the literature. Fortschritte Medicine, 112, 317 321.
  • 5
    Gordon, F.H., Mistry, P.K., Sabin, C.A., Lee, C.A. (1998) Outcome of orthotopic liver transplantation in patients with haemophilia. Gut, 42, 744 749.
  • 6
    Hanley, J.P., Jarvis, L.M., Andrew, J., Dennis, R., Hayes, P.C., Piris, J., Lee, R., Simmonds, P., Ludlam, C.A. (1996) Interferon treatment for chronic hepatitis C infection in hemophiliacs — influence of virus load, genotype, and liver pathology on response. Blood, 87, 1704 1709.
  • 7
    Hultgren, C., Milich, D.R., Weiland, O., Sallberg, M. (1998) The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. Journal of General Virology, 79, 2381 2391.
  • 8
    Makris, M., Preston, F.E., Triger, D.R., Underwood, J.C., Westlake, L., Adelman, M.I. (1991) A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood, 78, 1672 1677.
  • 9
    Makris, M., Preston, F.E., Rosendaal, F.R., Underwood, J.C., Rice, K.M., Triger, D.R. (1996) The natural history of chronic hepatitis C in haemophiliacs. British Journal of Haematology, 94, 746 752.
  • 10
    Mauser-Bunschoten, E.P., Bresters, D., Van Drimmelen, A.A., Roosendaal, G., Cuypers, H.T., Reesink, H.W., Van Der Poel, C.L., Van Den Berg, H.M., Lelie, P.N. (1995) Hepatitis C infection and viremia in Dutch hemophilia patients. Journal of Medicine and Virology, 45, 241 246.
  • 11
    McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.H., Cort, S., Albrecht, J.K. (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New England Journal of Medicine, 339, 1485 1492.
  • 12
    Poynard, T., Marcellin, P., Lee, S.S., Niederau, C., Minuk, G.S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., Albrecht, J. (1998) Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet, 352, 1426 1432.DOI: 10.1016/s0140-6736(98)07124-4
  • 13
    Rumi, M.G., Santagostino, E., Morfini, M., Gringeri, A., Tagariello, G., Chistolini, A., Pontisso, P., Tagger, A., Colombo, M., Mannucci, P.M. (1997) A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers. Blood, 89, 3529 3533.
  • 14
    Schalm, S.W., Hansen, B.E., Chemello, L., Bellobuono, A., Brouwer, J.T., Weiland, O., Cavalletto, L., Schvarcz, R., Ideo, G., Alberti, A. (1997) Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. Journal of Hepatology, 26, 961 966.
  • 15
    Telfer, P., Sabin, C., Devereux, H., Scott, F., Dusheiko, G., Lee, C. (1994) The progression of HCV-associated liver disease in a cohort of haemophilic patients. British Journal of Haematology, 87, 555 561.
  • 16
    Veerabagu, M.P., Finkelstein, S.D., Rabinovitz, M. (1997) Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha. Digestive Disease Science, 42, 1445 1448.
  • 17
    Watson, H.G., Ludlam, C.A., Rebus, S., Zhang, L.Q., Peutherer, J.F., Simmonds, P. (1992) Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. British Journal of Haematology, 80, 514 518.